Literature DB >> 22052170

Life-threatening and fatal infections in children with acute myeloid leukemia: a report from the Children's Oncology Group.

Lillian Sung1, Allen Buxton, Alan Gamis, William G Woods, Todd A Alonzo.   

Abstract

To determine among children with acute myeloid leukemia, whether the proportions of life-threatening or fatal infections differed according to the intensity of induction or type of intensification treatment. Participants were children enrolled to the Children's Cancer Group (CCG) 2891 with de novo acute myeloid leukemia. In phase 1 (induction) patients were randomized to 4 cycles of chemotherapy either administered as intensive or standard timing. In phase 2 (intensification), those achieving remission were allocated to allogeneic stem cell transplantation (SCT) if a suitable family donor was available while the remainder were randomized to autologous SCT or chemotherapy. Each infection was classified prospectively as nonlife-threatening, life-threatening, or fatal. The proportion of all infections that were considered life-threatening or fatal was higher with intensive timing compared with standard timing induction (60.3% vs. 37.3%, P<0.0001). Infections caused by Gram-positive and Gram-negative bacteria and fungi were significantly more likely to be severe during intensive compared with standard timing induction. Most molds were life-threatening or fatal. Chemotherapy intensification was not associated with less severe infections compared with SCT. Intensive timing was associated with more severe infections compared with standard timing induction. Prophylactic strategies are likely more important with intensive induction regimens.

Entities:  

Mesh:

Year:  2012        PMID: 22052170      PMCID: PMC4490686          DOI: 10.1097/MPH.0b013e31822817a6

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  15 in total

1.  Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group.

Authors:  W G Woods; N Kobrinsky; J D Buckley; J W Lee; J Sanders; S Neudorf; S Gold; D R Barnard; J DeSwarte; K Dusenbery; D Kalousek; D C Arthur; B J Lange
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

2.  Microbiologically documented infections and infection-related mortality in children with acute myeloid leukemia.

Authors:  Lillian Sung; Beverly J Lange; Robert B Gerbing; Todd A Alonzo; James Feusner
Journal:  Blood       Date:  2007-07-27       Impact factor: 22.113

3.  Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukemia: results of the United Kingdom Medical Research Council's 10th AML trial. MRC Childhood Leukaemia Working Party.

Authors:  R F Stevens; I M Hann; K Wheatley; R G Gray
Journal:  Br J Haematol       Date:  1998-04       Impact factor: 6.998

4.  Impact of granulocyte colony-stimulating factor use during induction for acute myelogenous leukemia in children: a report from the Children's Cancer Group.

Authors:  Todd A Alonzo; Nathan L Kobrinsky; Alexander Aledo; Beverly J Lange; Allen B Buxton; William G Woods
Journal:  J Pediatr Hematol Oncol       Date:  2002-11       Impact factor: 1.289

5.  Early deaths and treatment-related mortality in children undergoing therapy for acute myeloid leukemia: analysis of the multicenter clinical trials AML-BFM 93 and AML-BFM 98.

Authors:  Ursula Creutzig; Martin Zimmermann; Dirk Reinhardt; Michael Dworzak; Jan Stary; Thomas Lehrnbecher
Journal:  J Clin Oncol       Date:  2004-11-01       Impact factor: 44.544

Review 6.  Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia.

Authors:  Yasuhiro Okamoto; Raul C Ribeiro; Deo Kumar Srivastava; Jerry L Shenep; Ching-Hon Pui; Bassem I Razzouk
Journal:  J Pediatr Hematol Oncol       Date:  2003-09       Impact factor: 1.289

7.  Neutropenic fever and severe sepsis in adult acute myeloid leukemia (AML) patients receiving intensive chemotherapy: Causes and consequences.

Authors:  Sari Hämäläinen; Taru Kuittinen; Irma Matinlauri; Tapio Nousiainen; Irma Koivula; Esa Jantunen
Journal:  Leuk Lymphoma       Date:  2008-03

8.  Predictors of viridans streptococcal shock syndrome in bacteremic children with cancer and stem-cell transplant recipients.

Authors:  Adam Gassas; Ronald Grant; Susan Richardson; L Lee Dupuis; John Doyle; Upton Allen; Oussama Abla; Lillian Sung
Journal:  J Clin Oncol       Date:  2004-04-01       Impact factor: 44.544

9.  Infections and association with different intensity of chemotherapy in children with acute myeloid leukemia.

Authors:  Lillian Sung; Alan Gamis; Todd A Alonzo; Allen Buxton; Kristen Britton; Joetta Deswarte-Wallace; William G Woods
Journal:  Cancer       Date:  2009-03-01       Impact factor: 6.860

10.  Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.

Authors:  T Lehrnbecher; D Varwig; J Kaiser; D Reinhardt; T Klingebiel; U Creutzig
Journal:  Leukemia       Date:  2004-01       Impact factor: 11.528

View more
  10 in total

1.  Effect of age and body weight on toxicity and survival in pediatric acute myeloid leukemia: results from NOPHO-AML 2004.

Authors:  Ditte J A Løhmann; Jonas Abrahamsson; Shau-Yin Ha; Ólafur G Jónsson; Minna Koskenvuo; Birgitte Lausen; Josefine Palle; Bernward Zeller; Henrik Hasle
Journal:  Haematologica       Date:  2016-07-28       Impact factor: 9.941

Review 2.  Children's Oncology Group's 2013 blueprint for research: cancer control and supportive care.

Authors:  Lillian Sung; Theo Zaoutis; Nicole J Ullrich; Donna Johnston; Lee Dupuis; Elena Ladas
Journal:  Pediatr Blood Cancer       Date:  2012-12-19       Impact factor: 3.167

Review 3.  Concise review: next-generation cell therapies to prevent infections in neutropenic patients.

Authors:  Marion E G Brunck; Lars K Nielsen
Journal:  Stem Cells Transl Med       Date:  2014-03-05       Impact factor: 6.940

4.  Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia.

Authors:  Lane H Miller; Frank Keller; Ann Mertens; Mitchel Klein; Kristen Allen; Sharon Castellino; William G Woods
Journal:  Pediatr Blood Cancer       Date:  2019-09-10       Impact factor: 3.167

5.  Inducible epithelial resistance protects mice against leukemia-associated pneumonia.

Authors:  Miguel M Leiva-Juárez; Hayden H Ware; Vikram V Kulkarni; Patrick A Zweidler-McKay; Michael J Tuvim; Scott E Evans
Journal:  Blood       Date:  2016-06-17       Impact factor: 22.113

6.  Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.

Authors:  Sarah Alexander; Brian T Fisher; Aditya H Gaur; Christopher C Dvorak; Doojduen Villa Luna; Ha Dang; Lu Chen; Michael Green; Michael L Nieder; Beth Fisher; L Charles Bailey; John Wiernikowski; Lillian Sung
Journal:  JAMA       Date:  2018-09-11       Impact factor: 56.272

Review 7.  The under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic review.

Authors:  Briony F Hudson; Linda Jm Oostendorp; Bridget Candy; Victoria Vickerstaff; Louise Jones; Monica Lakhanpaul; Myra Bluebond-Langner; Paddy Stone
Journal:  Palliat Med       Date:  2016-09-08       Impact factor: 4.762

Review 8.  Imaging of acute and subacute toxicities of cancer therapy in children.

Authors:  Govind B Chavhan; Paul S Babyn; Paul C Nathan; Sue C Kaste
Journal:  Pediatr Radiol       Date:  2015-10-12

Review 9.  Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.

Authors:  Jill King; Zoi-Dorothea Pana; Thomas Lehrnbecher; William J Steinbach; Adilia Warris
Journal:  J Pediatric Infect Dis Soc       Date:  2017-09-01       Impact factor: 3.164

10.  Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.

Authors:  Thomas Lehrnbecher; Brian T Fisher; Bob Phillips; Sarah Alexander; Roland A Ammann; Melissa Beauchemin; Fabianne Carlesse; Elio Castagnola; Bonnie L Davis; L Lee Dupuis; Grace Egan; Andreas H Groll; Gabrielle M Haeusler; Maria Santolaya; William J Steinbach; Marianne van de Wetering; Joshua Wolf; Sandra Cabral; Paula D Robinson; Lillian Sung
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.